EMA provides guidelines for another unauthorized Covid-19 tablet

On Thursday, the European Medicines Agency (EMA) issued advice pertaining to Pfizer's Covid-19 tablet treatment Paxlovid, prior to market approval. The same day, Denmark allowed the use of MSD's similar treatment, Lagevrio.
Photo: HANDOUT/AFP / Pfizer
Photo: HANDOUT/AFP / Pfizer
by MIKKEL AABENHUS HEMMINGSEN, translated by daniel pedersen

On Thursday, as Denmark decided to allow use of MSD's Lagevrio (molnupiravir) a pill treatment that has not yet been approved by the European Medicines Agency (EMA), the agency decided to issue advice for another unauthorized drug.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading